超分辨率超声影像组学预测乳腺癌的多中心研究
本研究纳入中国12家医院742例女性乳腺病变患者,回顾性构建并验证结合B型超声、超分辨率超声与临床参数的影像组学模型。结果显示联合模型内部AUC为0.921,外部验证AUC为0.872,在BI-RADS 4A亚组阴性预测值达97.5%。
要点
- 联合B型超声、超分辨率超声参数图与临床信息可提高乳腺良恶性鉴别效能
- BI-RADS 4A病变中该模型阴性预测值达97.5%,有助于减少不必要的活检
- 超分辨率超声微血管组学提供自动化的微血管定量表征方法
核心结论
- 结合B型超声、超分辨率超声与临床参数的影像组学模型在预测乳腺癌中表现稳健,可作为基于超分辨率超声的微血管组学分析参考流程。
研究设计与样本
- 回顾性多中心研究,纳入2024年9月至2025年3月中国12家医院742例女性患者,平均年龄49.6±13.2岁。
- 557例作为训练队列并进行五折交叉验证,185例作为外部验证队列。
- 每幅B型超声图像提取73个影像组学特征,每幅超分辨率超声图像提取73个影像组学特征和45个颜色特征。
- 临床变量包括患者年龄、孕产史及乳腺癌家族史。
关键影像表现/征象
- 常规二维超声(B型)图像经处理后用于提取影像组学特征,是模型输入之一。
- 超分辨率超声生成四类参数图,并与B型图像共同参与影像组学特征提取与建模。
- 超分辨率超声图像除影像组学特征外,另提取颜色特征用于微血管定量表征。
诊断标准与关键数值
- 最佳临床-影像组学模型为B型图像、四类超分辨率超声参数图与临床参数的联合模型。
- 联合模型内部AUC为0.921±0.023,外部验证AUC为0.872±0.006。
- 在BI-RADS 4A亚组中,联合模型AUC为0.876±0.017,阴性预测值为97.5%。
临床应用与阅片要点
- 对BI-RADS 4A病变可尝试借助该联合模型辅助判断,当模型预测为阴性时活检必要性可进一步讨论。
- 阅片与报告时可关注B型超声特征与超分辨率超声微血管参数的综合信息,而非仅依赖单一模态。
- 影像组学模型依赖标准化的图像采集与特征提取流程,临床应用前需确认设备与重建参数一致性。
局限性
- 本研究为回顾性设计,存在选择偏倚可能。
- 研究时间跨度较短,未报告长期随访或临床结局验证。
- 原文未明确说明参考标准为病理还是随访,也未报告各中心设备与超分辨率超声重建方案的具体差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Harnessing super-resolution ultrasound (SRUS) for breast lesion characterization has been limited by manual, parameter-based analyses. Microvasculomics offers an automated solution for quantitative microvascular characterization. We aim to develop and validate a radiomic framework integrating B-mode ultrasound (US), SRUS, and clinical parameters for distinguishing benign from malignant breast lesions.
MATERIALS AND METHODS: In this retrospective, multicenter study, 742 female patients (age 49.6 ± 13.2 years) were enrolled from 12 hospitals in China between September 2024 and March 2025. Of these, 557 patients formed the training cohort with five-fold cross-validation and 185 comprised the external validation cohort. Seventy-three radiomic features were extracted from each B-mode image. For each SRUS image, 73 radiomic features and 45 color features were extracted. Clinical variables included patient age, obstetric history, and family history of breast cancer. Feature selection employed Mann-Whitney U testing, Spearman correlation filtering, and least absolute shrinkage and selection operator regression. Support vector machine models were constructed using either single-modality data or multimodal inputs via multi-kernel learning.
RESULTS: The best clinical-radiomic model combining B-mode images, four SRUS maps, and clinical parameters achieved an AUC of 0.921 ± 0.023 internally and 0.872 ± 0.006 externally. In the diagnostically challenging Breast Imaging Reporting and Data System 4A subgroup, it yielded an AUC of 0.876 ± 0.017 and a negative predictive value of 97.5%.
CONCLUSION: The proposed radiomics framework, integrating B-mode US, SRUS, and clinical information, demonstrates robust performance in predicting breast cancer and provides a reference pipeline for SRUS-based microvasculomic analysis.
引用
- Xu, Zheng, Jia, et al. Predicting Breast Cancer with Super-Resolution Ultrasound-Based Radiomics: A Multicenter Retrospective Study. Acad Radiol. 2026. PMID: 42570906. doi:10.1016/j.acra.2026.07.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。